Investigation of Some Antiviral N-Heterocycles as COVID 19 Drug: Molecular Docking and DFT Calculations
暂无分享,去创建一个
H. Ahmed | M. Hagar | Mohamed Hagar | Hoda A Ahmed | Ghadah Aljohani | Omaima A Alhaddad | O. Alhaddad | Ghadah Aljohani
[1] Wu Zhong,et al. Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro , 2020, Cell Discovery.
[2] P. Glue,et al. The clinical pharmacology of ribavirin. , 1999, Seminars in liver disease.
[3] Cheng‐He Zhou,et al. Heterocyclic Naphthalimides as New Skeleton Structure of Compounds with Increasingly Expanding Relational Medicinal Applications. , 2016, Current topics in medicinal chemistry.
[4] William A. Lee,et al. Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys , 2016, Nature.
[5] H. Ji,et al. Bi-directional differentiation of single bronchioalveolar stem cells during lung repair , 2020, Cell Discovery.
[6] S. Periandy,et al. NBO, conformational, NLO, HOMO-LUMO, NMR and electronic spectral study on 1-phenyl-1-propanol by quantum computational methods. , 2015, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.
[7] K. Chaieb,et al. N-alkyl 2-pyridone versus O-alkyl 2-pyridol: Ultrasonic synthesis, DFT, docking studies and their antimicrobial evaluation , 2020 .
[8] Xu Liu,et al. In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[9] T. Pal,et al. DFT investigations of linear Zn3-type complex with compartmental N/O-donor Schiff base: Synthesis, characterizations, crystal structure, fluorescence and molecular docking , 2020 .
[10] M. Uzzaman,et al. Physiochemical, molecular docking, and pharmacokinetic studies of Naproxen and its modified derivatives based on DFT , 2018, International Journal of Scientific Research and Management.
[11] J. Hay,et al. The effect of 2'-fluoro-2'-deoxycytidine on herpes virus growth. , 1985, Biochimica et biophysica acta.
[12] S. Parveen,et al. Computational and molecular docking approaches of a New axially chiral BODIPY fluorescent dye , 2020 .
[13] S. Parveen,et al. A new chiral boron-dipyrromethene (BODIPY)-based fluorescent probe: molecular docking, DFT, antibacterial and antioxidant approaches , 2019, Journal of biomolecular structure & dynamics.
[14] D. Smee,et al. Favipiravir (T-705), a novel viral RNA polymerase inhibitor. , 2013, Antiviral research.
[15] H. Ghabbour,et al. Spectroscopic identification, structural features, Hirshfeld surface analysis and molecular docking studies on stiripentol: An orphan antiepileptic drug , 2019, Journal of Molecular Structure.
[16] R. Shetty,et al. Therapeutic opportunities to manage COVID-19/SARS-CoV-2 infection: Present and future , 2020, Indian journal of ophthalmology.
[17] D. Hangauer,et al. Modulating hydrogen-bond basicity within the context of protein-ligand binding: A case study with thrombin inhibitors that reveals a dominating role for desolvation. , 2017, European journal of medicinal chemistry.
[18] M. M. Hoque,et al. Molecular Recognition of Azelaic Acid and Related Molecules with DNA Polymerase I Investigated by Molecular Modeling Calculations , 2016, Interdisciplinary Sciences: Computational Life Sciences.
[19] N. Kurita,et al. Specific interactions between tau protein and curcumin derivatives: Molecular docking and ab initio molecular orbital simulations. , 2020, Journal of molecular graphics & modelling.
[20] R. Baric,et al. Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV , 2020, Nature Communications.
[21] F. Cheng,et al. Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2 , 2020, Cell Discovery.
[22] Xiliang Wang,et al. COVID-19: a new challenge for human beings , 2020, Cellular & Molecular Immunology.
[23] Kai Zhao,et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin , 2020, Nature.
[24] R. Nussinov,et al. Computational network biology: Data, models, and applications , 2020 .
[25] Shiew-Mei Huang,et al. Physiologically Based Pharmacokinetic Modeling in Regulatory Science: An Update From the U.S. Food and Drug Administration's Office of Clinical Pharmacology. , 2019, Journal of pharmaceutical sciences.
[26] N. Linton,et al. Serial interval of novel coronavirus (COVID-19) infections , 2020, International Journal of Infectious Diseases.
[27] G. Gao,et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019 , 2020, The New England journal of medicine.
[28] Andrzej Kloczkowski,et al. Role of Resultant Dipole Moment in Mechanical Dissociation of Biological Complexes , 2018, Molecules.
[29] Sheng-Yong Yang,et al. Individualized network-based drug repositioning infrastructure for precision oncology in the panomics era , 2016, Briefings Bioinform..
[30] S. Tang,et al. COVID-19: An Update on the Epidemiological, Clinical, Preventive and Therapeutic Evidence and Guidelines of Integrative Chinese-Western Medicine for the Management of 2019 Novel Coronavirus Disease. , 2020, The American journal of Chinese medicine.
[31] Yunhui Liu,et al. Potential interventions for novel coronavirus in China: A systematic review , 2020, Journal of medical virology.
[32] Cynthia Liu,et al. Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases , 2020, ACS central science.
[33] Feixiong Cheng,et al. In Silico Oncology Drug Repositioning and Polypharmacology. , 2018, Methods in molecular biology.
[34] R. Rubbiani,et al. N-Heterocyclic carbene metal complexes in medicinal chemistry. , 2013, Dalton transactions.
[35] M. L. Serrano,et al. Unrevealing sequence and structural features of novel coronavirus using in silico approaches: The main protease as molecular target , 2020, EXCLI journal.
[36] David S. Goodsell,et al. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility , 2009, J. Comput. Chem..
[37] F. Cheng,et al. Drug Repurposing: New Treatments for Zika Virus Infection? , 2016, Trends in molecular medicine.
[38] P. Lekcharoensuk,et al. In silico and in vitro analysis of small molecules and natural compounds targeting the 3CL protease of feline infectious peritonitis virus , 2019, Antiviral Research.
[39] Ning Zhu,et al. Emerging Understanding of Etiology and Epidemiology of the Novel Coronavirus (COVID-19) infection in Wuhan, China , 2020 .
[40] P. Garner,et al. Systematic review of amodiaquine treatment in uncomplicated malaria , 1996, The Lancet.
[41] Wu Zhong,et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro , 2020, Cell Research.
[42] D. Raoult,et al. New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? , 2020, International Journal of Antimicrobial Agents.
[43] Jerry Avorn,et al. The $2.6 billion pill--methodologic and policy considerations. , 2015, The New England journal of medicine.